Table 4: tetanus coveragea,b among pregnant women in countries that have not achieved Maternal and Neonatal Tetanus Elimination — WHO African Region, 2000, 2005, and 2010–2015 |
||||||||||||||||
|
|
2000 |
2005 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
||||||||
|
Country |
PAB |
TT2+ |
PAB |
TT2+ |
PAB |
TT2+ |
PAB |
TT2+ |
PAB |
TT2+ |
PAB |
TT2+ |
PAB |
TT2+ |
PAB |
TT2+ |
|
Angola |
60 |
NA |
75 |
53 |
75 |
87 |
70 |
79 |
72 |
78 |
75 |
83 |
78 |
76 |
78 |
71 |
|
Central African Republic |
36 |
20 |
48 |
34 |
86 |
50 |
80 |
81 |
66 |
76 |
66 |
33 |
60 |
53 |
60 |
52 |
|
Chad |
39 |
12 |
61 |
NA |
60 |
77 |
60 |
60 |
43 |
70 |
50 |
78 |
60 |
83 |
75 |
96 |
|
DR of Congo |
45 |
25 |
67 |
66 |
77 |
85 |
70 |
84 |
70 |
86 |
75 |
85 |
82 |
88 |
82 |
91 |
|
Ethiopia |
54 |
32 |
80 |
45 |
88 |
NA |
88 |
1 |
68 |
66 |
72 |
NA |
80 |
NA |
80 |
92 |
|
Guinea |
79 |
43 |
90 |
75 |
90 |
70 |
80 |
80 |
80 |
86 |
80 |
93 |
80 |
62 |
80 |
54 |
|
Kenya |
68 |
51 |
73 |
72 |
78 |
72 |
73 |
76 |
73 |
NA |
73 |
77 |
76 |
55 |
80 |
55 |
|
Mali |
50 |
62 |
86 |
63 |
85 |
59 |
89 |
60 |
89 |
66 |
85 |
95 |
85 |
86 |
85 |
63 |
|
Nigeria |
57 |
NA |
62 |
52 |
69 |
39 |
60 |
44 |
60 |
56 |
60 |
39 |
55 |
44 |
55 |
40 |
|
South Sudan |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
61 |
NA |
50 |
NA |
41 |
NA |
45 |
NA |
28 |
|
Averagec |
54 |
19 |
68 |
53 |
74 |
48 |
69 |
51 |
65 |
61 |
66 |
51 |
68 |
50 |
69 |
64 |
|
a. PAB=Protection at birth. PAB is usually defined as receiving 2 tetanus toxoid containing vaccine (TTCV) doses during the last birth, ≥2 TTCV doses with the last dose ≤3 years prior to the last birth, ≥3 doses with the last dose ≤5 years prior, ≥4 doses with the last dose ≤10 years prior, or ≥5 prior doses. WHO-UNICEF annual estimates of PAB were calculated on the basis of mathematical modeling WHO-UNICEF estimates of PAB coverage. Last updated July 15, 2016. Available from http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragepab.html Accessed December 18, 2016. b. TT2+ = Proportion of women who have received their second or subsequent dose of TTCV during pregnancy. Reported estimates of TT2+ coverage. Last updated November 18, 2016. Available from http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tscoveragett2plus.html Accessed December 18, 2016. c. Average calculated as [sum of (coverage x births)] / sum of births. Denominator of births available from United Nations, Department of Economic and Social Affairs, Population Division (2015). World Population Prospects: The 2015 Revision, DVD Edition. Available from https://esa.un.org/unpd/wpp/Download/Standard/Population/ Accessed on September 18, 2016. |
||||||||||||||||